The so-called “Bone Wars” of the 1880s, which pitted Edward Drinker Cope against Othniel Charles Marsh in a frenzy of fossil collection and discovery, may have marked the introduction of dinosaurs to the American public, but the second Jurassic dinosaur rush, which took place around the turn of the twentieth century, brought the prehistoric beasts back to life. These later expeditions—which involved new competitors hailing from leading natural history museums in New York, Chicago, and Pittsburgh—yielded specimens that would be reconstructed into the colossal skeletons that thrill visitors today in museum halls across the country. Reconsidering the fossil speculation, the museum displays, and the media frenzy that ushered dinosaurs into the American public consciousness, Paul Brinkman takes us back to the birth of dinomania, the modern obsession with all things Jurassic. Featuring engaging and colorful personalities and motivations both altruistic and ignoble, The Second Jurassic Dinosaur Rush shows that these later expeditions were just as foundational—if not more so—to the establishment of paleontology and the budding collections of museums than the more famous Cope and Marsh treks. With adventure, intrigue, and rivalry, this is science at its most swashbuckling.
A narrative microhistory of the Field Museum of Natural History's groundbreaking expedition to hunt and preserve rare African animal specimens for its collection before it went extinct due to modern progress and natural selection, a common view among natural historians as the 1800s came to a close"--
The so-called “Bone Wars” of the 1880s, which pitted Edward Drinker Cope against Othniel Charles Marsh in a frenzy of fossil collection and discovery, may have marked the introduction of dinosaurs to the American public, but the second Jurassic dinosaur rush, which took place around the turn of the twentieth century, brought the prehistoric beasts back to life. These later expeditions—which involved new competitors hailing from leading natural history museums in New York, Chicago, and Pittsburgh—yielded specimens that would be reconstructed into the colossal skeletons that thrill visitors today in museum halls across the country. Reconsidering the fossil speculation, the museum displays, and the media frenzy that ushered dinosaurs into the American public consciousness, Paul Brinkman takes us back to the birth of dinomania, the modern obsession with all things Jurassic. Featuring engaging and colorful personalities and motivations both altruistic and ignoble, The Second Jurassic Dinosaur Rush shows that these later expeditions were just as foundational—if not more so—to the establishment of paleontology and the budding collections of museums than the more famous Cope and Marsh treks. With adventure, intrigue, and rivalry, this is science at its most swashbuckling.
From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin’s Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field. Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization. Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines. Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality. Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues. Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues. Analyzes the cost-benefit and cost-effectiveness of different vaccine options. Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
Completely revised and updated, this respected reference offers comprehensive and current coverage of every aspect of vaccination--from development to use in reducing disease. It also includes access to a companion Web site for more coverage.
From the development of each vaccine to its use in reducing disease, Plotkin’s Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field. Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues – plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. Analyzes the cost-benefit and cost-effectiveness of different vaccine options. Helps you clearly visualize concepts and objective data through an abundance of tables and figures. Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine. Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines. Features a new chapter on maternal immunization.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.